A carregar...
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy Related Toxicities
Chimeric antigen receptor T-cell (CAR-T) therapy has proven to be a very effective cancer immunotherapy. Axicabtagene ciloleucel and Tisagenlecleucel are the first in class anti-CD19 CAR-T-cells currently available for relapsed-refractory adult large B-cell lymphoma. Tisagenlecleucel is also availab...
Na minha lista:
| Publicado no: | BioDrugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733400/ https://ncbi.nlm.nih.gov/pubmed/30560413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0324-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|